Coeptis Therapeutics Holdings, Inc. (ZSQR) Cash flow
Market cap
$57.63M
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | 1 | 1 | 1 |
| Stock-based compensation | - | - | - | 477,503 | 1 |
| Cash from operations | -115,695 | -502,839 | -3,875,811 | -7,239,514 | -6,649,281 |
| Cash from investing | -75,750,000 | - | - | - | - |
| Cash from financing | 77 | - | 5 | 5 | 6 |